MLH1 and carcinoma: Regarding intramucosal carcinomas, 42.9% (nine of 21) of the reduced or absent Fhit expression carcinomas were negative for Mlh1 expression, whereas 14.7% (five of 34) of the preserved or intermediate Fhit expression carcinomas were Mlh1 negative (P=0.044).